Best-Rated GLP-1 Telehealth Providers

We weight four factors transparently: pricing (35%), user experience (25%), medication variety (20%), and insurance acceptance (20%). Full methodology is published at /how-we-rank — no provider can pay for a higher rank.

We earn affiliate commission when readers sign up through our links. The commission does not affect rank order. Our scoring formula is published and the same formula is applied to every provider, including ones we do not have an affiliate partnership with.

Quarterly. We re-pull every provider’s current pricing, medication list, state availability, and insurance acceptance before each refresh. Major changes (new drug approval, manufacturer-direct pricing shift, FDA shortage status) trigger an off-cycle update with a published changelog.

Most ranked providers prescribe at least one branded GLP-1 (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, or Rybelsus). Medication availability varies by state, BMI eligibility, and current FDA shortage status. Each provider’s page lists exactly which medications they currently dispense.

Cash-pay GLP-1 telehealth ranges from roughly $349/month (manufacturer-direct programs like LillyDirect for Zepbound vials, NovoCare Pharmacy for Wegovy) up to $1,300/month for branded pens through some retail-pharmacy channels. Membership fees ($25-$99/month) and labs are usually billed separately from the medication itself.

Some providers (Found, Sequence, Calibrate) bill insurance directly; others (Ro, Hims) operate cash-pay only and provide a superbill you can submit yourself. Coverage depends on your insurer’s formulary, BMI eligibility, prior-authorization requirements, and whether the drug is approved for weight management or only type 2 diabetes under your plan.

For semaglutide: the FDA shortage was resolved in May 2024 and ordinary 503A compounding is no longer permitted for patients without a clinical need. For tirzepatide: shortage resolved December 2024 with a wind-down window through 2025. Personalized compounded formulations from licensed 503A pharmacies remain available for documented individual patient needs.

Most ranked providers offer a money-back guarantee on unused medication or first-month membership. Switching between providers is straightforward — most accept records from another telehealth provider without requiring a new in-person consult. See our /switching guides for medication-specific dose-equivalence and washout protocols.